Alteplase
1 NDC across 1 manufacturer|0 Generic,1 Brand
Alteplase is used to treat arterial occlusive diseases, intracranial embolism and thrombosis, myocardial infarction, pulmonary embolism and stroke, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Alteplase is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $186.38 to $186.38 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$186.38 – $186.38
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Genentech, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ALTEPLASE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CATHFLO ACTIVASE 2 MG VIAL | $186.3796 per EA | — |
Frequently Asked Questions
What is Alteplase used to treat?
Alteplase is used to treat arterial occlusive diseases, intracranial embolism and thrombosis, myocardial infarction, pulmonary embolism and stroke, per the National Library of Medicine's MED-RT classification.
How many Alteplase products are on the market?
The Alteplase drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Alteplase?
NADAC reference prices for Alteplase range from $186.3796 to $186.3796 per EA.
Which manufacturers make Alteplase?
1 manufacturer lists Alteplase in NADAC. Ranked by number of NDCs, the largest are Genentech, Inc. (1).